Neurocrine Biosciences Stock Price History
| NBIX Stock | USD 126.75 0.16 0.13% |
Below is the normalized historical share price chart for Neurocrine Biosciences extending back to May 23, 1996. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Neurocrine Biosciences stands at 126.75, as last reported on the 30th of November, with the highest price reaching 127.08 and the lowest price hitting 125.50 during the day.
If you're considering investing in Neurocrine Stock, it is important to understand the factors that can impact its price. At this stage we consider Neurocrine Stock to be very steady. Neurocrine Biosciences has Sharpe Ratio of 0.0206, which conveys that the firm had a 0.0206% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Neurocrine Biosciences, which you can use to evaluate the volatility of the firm. Please verify Neurocrine Biosciences' Mean Deviation of 1.21, risk adjusted performance of 0.028, and Downside Deviation of 1.57 to check out if the risk estimate we provide is consistent with the expected return of 0.0345%.
At this time, Neurocrine Biosciences' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 3.4 B in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 61.8 M in 2024. . At this time, Neurocrine Biosciences' Price Earnings Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 6.13 in 2024, whereas Price To Sales Ratio is likely to drop 6.48 in 2024. Neurocrine Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 23rd of May 1996 | 200 Day MA 133.2912 | 50 Day MA 118.967 | Beta 0.353 |
Neurocrine |
Sharpe Ratio = 0.0206
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NBIX |
Estimated Market Risk
| 1.68 actual daily | 14 86% of assets are more volatile |
Expected Return
| 0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Neurocrine Biosciences is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neurocrine Biosciences by adding it to a well-diversified portfolio.
Price Book 4.714 | Enterprise Value Ebitda 21.2992 | Price Sales 5.7219 | Shares Float 100.1 M | Wall Street Target Price 163.4612 |
Neurocrine Biosciences Stock Price History Chart
There are several ways to analyze Neurocrine Stock price data. The simplest method is using a basic Neurocrine candlestick price chart, which shows Neurocrine Biosciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 26, 2024 | 127.91 |
| Lowest Price | October 9, 2024 | 111.62 |
Neurocrine Biosciences November 30, 2024 Stock Price Synopsis
Various analyses of Neurocrine Biosciences' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Neurocrine Stock. It can be used to describe the percentage change in the price of Neurocrine Biosciences from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Neurocrine Stock.| Neurocrine Biosciences Accumulation Distribution | 5,014 | |
| Neurocrine Biosciences Price Daily Balance Of Power | 0.10 | |
| Neurocrine Biosciences Price Action Indicator | 0.54 | |
| Neurocrine Biosciences Price Rate Of Daily Change | 1.00 |
Neurocrine Biosciences November 30, 2024 Stock Price Analysis
Neurocrine Stock Price History Data
The price series of Neurocrine Biosciences for the period between Sun, Sep 1, 2024 and Sat, Nov 30, 2024 has a statistical range of 16.81 with a coefficient of variation of 3.9. The daily prices for the period are spread out with arithmetic mean of 119.89. The median price for the last 90 days is 120.17. The company issued dividends to stockholders on 1995-12-29.| Open | High | Low | Close | Volume | ||
| 11/29/2024 | 126.15 | 127.08 | 125.50 | 126.75 | 403,268 | |
| 11/27/2024 | 127.91 | 128.27 | 125.43 | 126.59 | 739,665 | |
| 11/26/2024 | 127.15 | 128.14 | 124.23 | 127.91 | 757,856 | |
| 11/25/2024 | 125.94 | 127.81 | 125.02 | 127.11 | 1,563,590 | |
| 11/22/2024 | 125.18 | 127.00 | 124.38 | 125.65 | 1,206,787 | |
| 11/21/2024 | 123.27 | 126.13 | 122.37 | 125.00 | 1,201,799 | |
| 11/20/2024 | 119.36 | 124.01 | 118.91 | 123.29 | 1,435,150 | |
| 11/19/2024 | 116.34 | 119.79 | 115.27 | 119.13 | 1,092,819 | |
| 11/18/2024 | 117.46 | 118.32 | 116.33 | 117.62 | 1,045,412 | |
| 11/15/2024 | 122.10 | 122.69 | 117.36 | 117.44 | 1,255,337 | |
| 11/14/2024 | 125.53 | 125.89 | 122.58 | 122.88 | 876,531 | |
| 11/13/2024 | 127.19 | 127.84 | 125.51 | 125.51 | 807,393 | |
| 11/12/2024 | 126.95 | 128.24 | 126.39 | 127.01 | 893,295 | |
| 11/11/2024 | 125.77 | 129.67 | 125.75 | 127.17 | 1,267,684 | |
| 11/08/2024 | 124.91 | 126.28 | 123.76 | 125.74 | 561,756 | |
| 11/07/2024 | 125.29 | 126.65 | 123.50 | 123.98 | 755,190 | |
| 11/06/2024 | 124.10 | 126.48 | 122.47 | 125.30 | 1,214,670 | |
| 11/05/2024 | 120.01 | 122.00 | 119.08 | 121.53 | 748,197 | |
| 11/04/2024 | 121.27 | 122.32 | 119.70 | 120.53 | 1,018,488 | |
| 11/01/2024 | 120.52 | 123.00 | 120.52 | 122.21 | 1,512,407 | |
| 10/31/2024 | 122.52 | 123.04 | 119.42 | 120.27 | 1,362,570 | |
| 10/30/2024 | 126.46 | 131.26 | 124.15 | 124.33 | 2,596,274 | |
| 10/29/2024 | 115.79 | 116.86 | 115.08 | 116.19 | 1,136,607 | |
| 10/28/2024 | 115.81 | 117.95 | 115.81 | 116.20 | 676,278 | |
| 10/25/2024 | 115.69 | 117.41 | 113.88 | 116.08 | 1,009,703 | |
| 10/24/2024 | 115.55 | 117.57 | 114.45 | 115.52 | 797,395 | |
| 10/23/2024 | 116.37 | 116.69 | 114.55 | 115.08 | 581,975 | |
| 10/22/2024 | 115.68 | 117.20 | 115.68 | 116.78 | 576,884 | |
| 10/21/2024 | 117.34 | 117.89 | 116.14 | 116.57 | 550,819 | |
| 10/18/2024 | 118.06 | 119.11 | 117.41 | 118.01 | 1,006,025 | |
| 10/17/2024 | 118.73 | 119.07 | 118.03 | 118.46 | 728,016 | |
| 10/16/2024 | 116.64 | 120.11 | 116.59 | 118.35 | 864,256 | |
| 10/15/2024 | 116.57 | 117.97 | 116.21 | 117.34 | 955,897 | |
| 10/14/2024 | 115.13 | 116.69 | 115.03 | 116.44 | 623,911 | |
| 10/11/2024 | 112.41 | 116.29 | 112.16 | 115.49 | 781,035 | |
| 10/10/2024 | 111.69 | 112.57 | 111.14 | 112.41 | 487,941 | |
| 10/09/2024 | 111.77 | 112.58 | 111.21 | 111.62 | 373,128 | |
| 10/08/2024 | 111.68 | 112.21 | 110.99 | 111.66 | 684,633 | |
| 10/07/2024 | 114.09 | 114.09 | 111.87 | 112.16 | 573,421 | |
| 10/04/2024 | 113.22 | 114.18 | 112.18 | 114.00 | 784,252 | |
| 10/03/2024 | 113.66 | 114.05 | 110.95 | 111.88 | 1,323,892 | |
| 10/02/2024 | 115.31 | 115.31 | 113.00 | 113.95 | 730,304 | |
| 10/01/2024 | 114.94 | 114.96 | 112.83 | 114.15 | 718,280 | |
| 09/30/2024 | 115.24 | 115.90 | 114.12 | 115.22 | 882,499 | |
| 09/27/2024 | 116.02 | 116.41 | 114.95 | 115.06 | 936,435 | |
| 09/26/2024 | 114.93 | 117.11 | 114.57 | 115.93 | 643,416 | |
| 09/25/2024 | 117.09 | 117.09 | 114.08 | 114.55 | 1,123,424 | |
| 09/24/2024 | 117.89 | 117.89 | 115.93 | 116.49 | 881,986 | |
| 09/23/2024 | 118.39 | 119.74 | 117.00 | 117.75 | 948,094 | |
| 09/20/2024 | 120.28 | 120.28 | 117.00 | 118.35 | 1,282,568 | |
| 09/19/2024 | 121.30 | 122.81 | 119.66 | 120.46 | 788,199 | |
| 09/18/2024 | 123.00 | 123.49 | 119.37 | 119.85 | 1,049,116 | |
| 09/17/2024 | 122.50 | 123.52 | 121.00 | 122.31 | 757,338 | |
| 09/16/2024 | 122.91 | 123.57 | 121.94 | 122.25 | 721,315 | |
| 09/13/2024 | 120.19 | 123.39 | 119.82 | 122.25 | 917,801 | |
| 09/12/2024 | 121.04 | 122.09 | 119.49 | 121.28 | 530,666 | |
| 09/11/2024 | 119.67 | 122.25 | 119.06 | 121.47 | 1,056,416 | |
| 09/10/2024 | 120.18 | 120.77 | 118.04 | 119.10 | 1,083,092 | |
| 09/09/2024 | 120.14 | 122.30 | 119.75 | 120.64 | 1,022,780 | |
| 09/06/2024 | 122.20 | 122.75 | 119.85 | 120.17 | 868,967 | |
| 09/05/2024 | 122.49 | 123.64 | 119.92 | 121.21 | 2,192,563 |
About Neurocrine Biosciences Stock history
Neurocrine Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neurocrine is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neurocrine Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neurocrine Biosciences stock prices may prove useful in developing a viable investing in Neurocrine Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 101 M | 61.8 M | |
| Net Income Applicable To Common Shares | 177.7 M | 186.6 M |
Neurocrine Biosciences Quarterly Net Working Capital |
|
Neurocrine Biosciences Stock Technical Analysis
Neurocrine Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
Neurocrine Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Neurocrine Biosciences' price direction in advance. Along with the technical and fundamental analysis of Neurocrine Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neurocrine to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.028 | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | (0.25) | |||
| Sortino Ratio | (0.06) | |||
| Treynor Ratio | 0.0354 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Neurocrine Stock Analysis
When running Neurocrine Biosciences' price analysis, check to measure Neurocrine Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurocrine Biosciences is operating at the current time. Most of Neurocrine Biosciences' value examination focuses on studying past and present price action to predict the probability of Neurocrine Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurocrine Biosciences' price. Additionally, you may evaluate how the addition of Neurocrine Biosciences to your portfolios can decrease your overall portfolio volatility.